Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases
Abstract
No abstract availableKeywords
Funding Information
- International Hepato-Pancreato-Biliary Association
This publication has 42 references indexed in Scilit:
- Tumor Thickness at the Tumor-normal Interface: A Novel Pathologic Indicator of Chemotherapy Response in Hepatic Colorectal MetastasesAmerican Journal of Surgical Pathology, 2010
- RECIST revised: implications for the radiologist. A review article on the modified RECIST guidelineEuropean Radiology, 2009
- Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastasesSurgery, 2009
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized TrialsJournal of Clinical Oncology, 2008
- Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastasesBMC Cancer, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107Journal of Clinical Oncology, 2008
- Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgeryAnnals of Oncology, 2006
- Unbiased Recursive Partitioning: A Conditional Inference FrameworkJournal of Computational and Graphical Statistics, 2006
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004